Eli Lilly and Co signed an agreement with the Bill & Melinda Gates Foundation to facilitate access to the company's future coronavirus drugs for low- and middle-income countries. The deal aims to accelerate the development and access to treatment for COVID-19. Capacities for production of Lilly drugs are already reserved. It may begin in April 2021 after regulatory approval.
Eli Lilly and Co signed an agreement with the Bill & Melinda Gates Foundation to facilitate access to the company's future coronavirus drugs for low- and middle-income countries. The deal aims to accelerate the development and access to treatment for COVID-19. Capacities for production of Lilly drugs are already reserved. It may begin in April 2021 after regulatory approval. 
investor.lilly.com
English (US) 